Authors: Fritsch G et al.
Anesthesiology, January 23, 2026, 10.1097/ALN.0000000000005950
This experimental study evaluated whether regional anesthesia using ropivacaine influences tissue injury during acute compartment syndrome (ACS). The use of regional anesthesia in patients at risk for compartment syndrome has long been controversial because clinicians worry that nerve blocks may mask pain and delay diagnosis. However, little research has examined whether regional anesthesia itself influences the underlying pathophysiology of compartment syndrome.
The investigators used a porcine model of acute compartment syndrome involving the tibialis anterior compartment. Twenty pigs were included and randomized to receive either regional anesthesia with ropivacaine 0.2% or placebo. Compartment syndrome was induced by inflating an angioplasty catheter within the muscle compartment to elevate compartment pressure.
Continuous monitoring was performed throughout the experiment, including measurements of compartment pressure and mean arterial pressure. Biological samples were obtained from both plasma and interstitial tissue fluid at multiple time points. The investigators measured several metabolic markers associated with tissue injury, including creatine kinase, lactate, lactate dehydrogenase, and glucose. At the end of the study period, tissue samples were also examined histologically to assess structural damage.
Interestingly, the ropivacaine-treated animals developed higher compartment pressures compared with controls. At the final time point, the median compartment pressure in the ropivacaine group reached approximately 57 mmHg compared with approximately 41 mmHg in the placebo group. Despite the higher pressure, systemic hemodynamics such as mean arterial pressure remained similar between groups.
Systemic biomarkers measured in plasma did not differ significantly between groups, suggesting that the overall systemic metabolic response was similar. However, important differences were observed within the local tissue environment.
Interstitial measurements showed markedly lower levels of tissue injury markers in animals receiving ropivacaine. Lactate dehydrogenase, a marker of cellular damage, was dramatically reduced in the ropivacaine group. Tissue glucose levels were also significantly lower, which may reflect improved cellular metabolic utilization rather than ischemic accumulation.
Histopathologic examination supported these biochemical findings. Muscle tissue exposed to ropivacaine demonstrated less degeneration and necrosis compared with tissue from the placebo group. These results indicate that regional anesthesia with ropivacaine appeared to mitigate cellular injury within the compartment despite elevated compartment pressure.
The investigators propose several possible mechanisms for these protective effects. Local anesthetics may improve microcirculatory perfusion, reduce inflammatory signaling, or alter cellular metabolic stress responses. The findings suggest that regional anesthesia may not necessarily worsen the underlying tissue injury associated with compartment syndrome and may even provide protective effects in certain circumstances.
However, the authors emphasize that this was a controlled experimental model and that clinical implications remain uncertain. One of the major concerns in clinical practice is not the biological effect of regional anesthesia itself but the possibility that analgesia could delay recognition of worsening compartment syndrome. Therefore, careful monitoring and clinical vigilance remain essential.
Overall, the study provides evidence that ropivacaine-based regional anesthesia may improve local metabolic conditions and reduce tissue injury in acute compartment syndrome, even when compartment pressures remain elevated. These findings suggest that the physiologic effects of regional anesthesia in compartment syndrome may be more complex than previously assumed and warrant further investigation in clinical settings.
What You Should Know
Regional anesthesia has traditionally been considered controversial in patients at risk for acute compartment syndrome because of concerns that it could mask symptoms.
This study suggests that ropivacaine-based regional anesthesia may actually reduce muscle tissue injury in an experimental compartment syndrome model.
Despite higher compartment pressures in the ropivacaine group, biochemical and histologic markers indicated less tissue damage.
The protective effects may involve improved microcirculation or reduced cellular metabolic stress.
These findings are experimental and do not change current clinical practice, but they challenge long-standing assumptions about regional anesthesia in compartment syndrome.
Key Points
A porcine model was used to study the effects of ropivacaine regional anesthesia during induced compartment syndrome.
Ropivacaine-treated animals had higher measured compartment pressures than controls.
Despite higher pressure, tissue injury markers in interstitial fluid were significantly lower.
Histologic analysis showed reduced muscle degeneration and necrosis in the ropivacaine group.
Systemic biomarkers and mean arterial pressure were similar between groups.
The results suggest that regional anesthesia may have tissue-protective effects in acute compartment syndrome.
Thank you to Anesthesiology for allowing us to summarize this article.